A unique N-glycan on human transferrin in CSF: a possible biomarker for iNPH

详细信息	查看全文 | 推荐本文 |

• 作者：Satoshi Futakawa^a ; ¹ ; Kiyomitsu Nara^a ; ¹ ; Masakazu Miyajima^b ; Atsushi Kuno^c ; Hiromi Ito^c ; ² ; Hiroyuki Kaji^c ; Keiro Shirotani^a ; Takashi Honda^d ; Yuriko Tohyama^a ; Kyoka Hoshi^a ; Yusuke Hanzawa^a ; Shinobu Kitazume^e ; Rie Imamaki^e ; Katsutoshi Furukawa^f ; Kazuhiro Tasaki^g ; Hiroyuki Arai^f ; Tatsuhiko Yuasa^h ; Masafumi Abe^g ; Hajime Arai^b ; Hisashi Narimatsu^c ; Yasuhiro Hashimoto^a ; ⁱ ; ^{yasuc@fmu.ac.jp}
• 关键词：N-glycan ; Transferrin ; Glycosylation ; Cerebrospinal fluid ; Choroid plexus ; Dementia ; Idiopathic normal pressure hydrocephalus ; Alzheimer's disease ; Biomarker
• 刊名：Neurobiology of Aging
• 出版年：2012
• 期刊代码：202_01974580
• 类别：med
• 出版时间：August, 2012
• 卷：33
• 期：8
• 页码：1807-1815
• 文件大小：1328 K

摘要

Idiopathic normal pressure hydrocephalus (iNPH) is an elderly dementia caused by abnormal metabolism in the cerebrospinal fluid (CSF). The tap test is the current basis for confirming iNPH, but it shows very low sensitivity, indicating that many patients who might be cured by a shunt operation will be missed. On sodium dodecyl sulfate-polyacrylamide gel electrophoresis, we found two transferrin isoforms: one had a unique N-glycan (Tf-1) whereas the other had N-glycan similar to that of serum transferrin (Tf-2). Glycan analyses revealed that Tf-1 had branching (biantennary) asialo- and agalacto-complex type N-glycans (N-acetylglucosamine [GlcNAc]-terminated glycans), which carried bisecting 尾1,4-N-acetylglucosamine and core 伪1,6-fucose. To examine glycoform whether changes in iNPH, we introduced the Tf-2/Tf-1 ratio as a diagnostic index, which minimized blot-to-blot variations in measurement. The Tf-2/Tf-1 ratios of iNPH patients are significantly higher than those of controls (p = 0.0019) and Alzheimer's patients (p = 0.0010). This suggests that the Tf-2/Tf-1 ratio could distinguish iNPH from Alzheimer's disease, and possibly other dementias. In conclusion, glycoform analysis has diagnostic potential in neurological diseases.